Abstract:Background: Estradiol, as an important hormone in follicular development and endometrial receptivity, is closely related to clinical outcomes of fresh in vitro fertilization embryo transfer (IVF-ET) cycles. The aim of this retrospective study was to evaluate the association between elevated serum estradiol (E-2) levels on the day of human chorionic gonadotrophin (hCG) administration and IVF-ET pregnancy and birth outcomes. Methods: A total of 1771 infertile patients with their first fresh IVF-ET cycles were analyzed retrospectively between January 2011 and January 2016 in Peking University First Hospital. Patients were categorized by serum E2 levels on the day of hCG administration into six groups: group 1 (serum E-2 levels < 1000 pg/mL, n = 205), group 2 (serum E-2 levels 1001-2000 pg/mL, n = 457), group 3 (serum E-2 levels 2001-3000 pg/mL, n = 425), group 4 (serum E-2 levels 3001-4000 pg/mL, n = 310), group 5 (serum E2 levels 40015000 pg/mL, n = 237), and group 6 (serum E-2 levels > 5000 pg/mL, n = 137). The retrieved oocyte and MII oocyte numbers and implantation and clinical pregnancy rates of the groups were compared as the first objective of the study. For the 360 women with singleton births among all patients, the area under the corresponding receiver operating characteristic curve (ROC curve) was calculated to assess the predictive value of the E-2 change for the probability of low birth weight (LBW) infants as the second objective. Results: The retrieved oocyte and MII oocyte numbers and implantation and clinical pregnancy rates gradually increased from groups 1 to 5 but decreased in group 6. The parameters of group 1 were statistically worse than those of the other groups, from group 2 to group 6 (the number of retrieved oocytes, t = 13.096, t = 23.307, t = 23.086, t = 26.376, t = 19.636, P < 0.003; the number of retrieved MII oocytes, t = 10.856, t = 20.868, t = 21.874, t = 23.374, t = 19.092, P < 0.003; the implantation rate, chi(2) = 12.179, chi(2) = 22.239, chi(2) = 23.993, chi(2) = 23.344, chi(2) = 16.758, P < 0.003; the clinical pregnancy rate, chi(2) = 16.415, chi(2) = 28.074, chi(2) = 35.387, chi(2) = 37.025, chi(2) = 24.590, P < 0.003). ROC analysis revealed that when a serum peak E-2 of 3148 pg/mL was used to predict LBW. Conclusions: The results indicate that serum E-2 levels have a concentration-dependent effect on clinical outcomes. The optimal range of the E-2 level during a fresh IVF-ET cycle is 1000 to 3148 pg/mL.

Levels of serum β-human chorionic gonadotropin after embryo transfer and subsequent miscarriage, pre-eclampsia, and intrauterine growth restriction

Can Single Progesterone Concentration Predict Miscarriage in Early Pregnant Women with Threatened Miscarriage: a Systematic Review and Meta-Analysis

Comparison of Progesterone Measurement on Day Of, and Day After, HCG Administration in IVF–embryo Transfer Cycles

Serum LH Levels on hCG Trigger Day Affect IVF Outcomes Intensified by Poor Ovarian Reserve and Advanced Age

Recurrent Ivf Failure Is Associated With Elevated Progesterone On The Day Of Hcg Administration

Association Between Luteinizing Hormone Level Decrease on the Triggering Day and Pregnancy Outcome for in Vitro Fertilization/intracytoplasmic Sperm Injection Patients Following Gonadotropin-Releasing Hormone Antagonist Protocol: a Retrospective Cohort Study

Association between LH level decrease on the triggering day and pregnancy outcome for IVF/ICSI patients following GnRH antagonist protocol: a retrospective cohort study

Serum concentrations of luteinizing hormone and progesterone in ovum recipients: their relationship with pregnancy and miscarriage

Value of levels of serumβ-chorionic gonadotropin and C-reactive protein in prediction of intrauterine infection of premature rupture of membranes and evaluation of prognosis

Combined analysis of human chorionic gonadotrophin concentrations at different time points after frozen-thawed blastocyst transfer can improve our ability to predict the pregnancy outcomes of single gestations

The Value of HCG Serum Concentrations after Trigger in Predicting Pregnancy and Live Birth Rates in IVF–ICSI

Association Between Serum Estradiol Level on the Human Chorionic Gonadotrophin Administration Day and Clinical Outcome.

Increased Maternal Serum Hcg Concentrations in the Presence of a Female Fetus As Early As 2 Weeks after IVF-ET.

Independent value of serum β-human chorionic gonadotropin in predicting early pregnancy loss risks in IVF/ICSI cycles

Predictive Value of Early Serum Beta-Human Chorionic Gonadotropin Measurements After Cleavage or Blastocyst Embryo Transfers

Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer?

Effects of Different Fertilizations Upon Serum HCG Level of IVF Versus ET in Early Pregnancy

Low LH Level on the Day of GnRH Agonist Trigger Is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer

Initial maternal serum human chorionic gonadotropin levels in pregnancies achieved after assisted reproductive technology are higher after preimplantation genetic screening and after frozen embryo transfer: a retrospective cohort

Paired Detection of Serum Human Chorionic Gonadotropin Possibly Predicting Pregnant Outcome after in Vitro Fertilization-a Large Scale Retrospective Research

Predictive value of serum HCG concentrations for outcomes of vitrified-warmed blastocyst transfers in women of different ages